Target intelligence / Profile preview

DNA alkylation by methylation at O6 and N7 positions of guanine bases

Molecular classification
DNA modification, Genomic alteration
01

Overview

DNA alkylation by methylation at O6 and N7 positions of guanine bases is a form of DNA damage primarily induced by the chemotherapeutic agent temozolomide (TMZ). The active metabolite, MTIC, transfers methyl groups to guanine bases, leading to DNA damage, cell cycle arrest, and apoptosis. The most cytotoxic lesion is O6-methylguanine, while N7-methylation is more frequent but less cytotoxic. Resistance to TMZ is often mediated by MGMT, which repairs O6-methylguanine lesions. MGMT expression levels and activity are important determinants of TMZ efficacy.

Other names
Temozolomide-induced DNA alkylationO6-methylguanine formationN7-methylguanine formationDNA Methylation by MTICTMZ-induced DNA damage
02

Mechanism of action

Temozolomide is a prodrug that converts to MTIC. MTIC methylates DNA at the O6 and N7 positions of guanine. O6-methylguanine mispairs with thymine leading to futile mismatch repair, double-strand breaks and apoptosis. N7-methylation can cause depurination and strand breaks.

03

Biological functions

DNA damageApoptosis inductionCell cycle arrestMutagenesis
04

Disease associations

CancerGlioblastoma
05

Safety considerations

MyelosuppressionOpportunistic infectionsSecondary malignancies
06

Interacting drugs

Temozolomide
07

Biomarkers

MGMT promoter methylation statusMGMT expression levelMLH1 expressionMSH2 expression

Beyond the preview

Go deeper on DNA alkylation by methylation at O6 and N7 positions of guanine bases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA alkylation by methylation at O6 and N7 positions of guanine bases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call